000 01218 a2200349 4500
005 20250513160552.0
264 0 _c19990126
008 199901s 0 0 eng d
022 _a0960-894X
024 7 _a10.1016/S0960-894X(98)00535-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchlienger, N
245 0 0 _aRational design of a new series of mixed anti-HIV pronucleotides.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cNov 1998
300 _a3003-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-HIV Agents
_xchemical synthesis
650 0 4 _aDrug Design
650 0 4 _aHumans
650 0 4 _aNucleotides
_xchemical synthesis
650 0 4 _aProdrugs
_xchemical synthesis
650 0 4 _aZidovudine
_xanalogs & derivatives
700 1 _aBeltran, T
700 1 _aPérigaud, C
700 1 _aLefebvre, I
700 1 _aPompon, A
700 1 _aAubertin, A M
700 1 _aGosselin, G
700 1 _aImbach, J L
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 8
_gno. 21
_gp. 3003-6
856 4 0 _uhttps://doi.org/10.1016/S0960-894X(98)00535-6
_zAvailable from publisher's website
999 _c9836083
_d9836083